To evaluate the potential of LD inhibition to treat ZIKV infection in vivo, we infected neonatal mice (P2) with daily intraperitoneal injections of the DGAT-1 inhibitor A922500 for seven days. The gene discussed is DGAT1; the disease is Zika virus infectious disease.